Making Breast Screening Even Safer
Screening mammograms become safer for all women when these exams are done every two years, rather than annually, as well as beginning at age 50 instead of 40 or 45, according to the study published in the Annals of Internal Medicine.
"For most women, the risks are very low," says first author Diana Miglioretti, professor of Biostatistics at UC Davis School of Medicine. "The one group I worry about is women with very large breasts who choose to be screened annually from ages 40 to 74. Most screening mammograms are two views per breast. Some women with large breasts need more than four views for a complete screening examination, increasing their exposure to ionising radiation."
The research team modelled the lifetime risk of women developing radiation-induced breast cancer from digital screening mammography and dying from the disease compared to the number of breast cancer deaths prevented by early detection. They found that biennial screening of 100,000 women, from ages 50 to 74, prevents 627 deaths. The radiation exposure from these screening exams, and any subsequent diagnostic workups, can cause 27 breast cancer cases and four breast cancer deaths. In contrast, annual screening from ages 40 to 74 increases these risks five-fold, leading to 100 additional radiation-induced breast cancers and 12 additional breast cancer deaths.
Moreover, the risks associated with screening mammograms increased in women with large breasts, who received 2.3 times more radiation than women with smaller breasts. These larger doses put them at risk for approximately 57 cases of breast cancer and 10 radiation-induced breast cancer deaths (per 100,000 women screened biennially, ages 50 to 74).
See Also: Mammographic Screening for Women with Dense Breasts
The study also found that false positives, which may require follow-up diagnostic mammograms and associated radiation, increased breast cancer risk. However, again, the risk varied with different groups.
While the study identifies women with large breasts at higher risk of radiation-induced cancer, new technologies may help mitigate that danger. For example, larger detectors can image women with very large breasts with fewer views and less radiation.
The research team emphasises that mammograms are extremely safe and their benefits outweigh the radiation risk. "For the majority of women, screening mammography is very safe," says Prof. Miglioretti. "And if you screen every other year between 50 and 74, that makes it safest."
The authors hope this study will help open a conversation between women and their providers.
"Women need to have a dialogue with their primary care providers about when to start screening, when to stop screening and how often to screen based on their personal values and the potential benefits and harms associated with each scenario," according to Christoph Lee, associate professor of radiology at the University of Washington School of Medicine, who contributed to the study.
Source: University of California - Davis Health System
Image credit: University of California Regents, 2016
Published on : Mon, 11 Jan 2016
The enlightened choice for high-field MRI ECHELON Smart is Hitachi’s smart MRI concept which combines ‘SmartQUALITY’ for superb clinical images and sophisticated applications, ‘SmartSPEED’ for reduced examination time, ‘SmartCOMFORT’ for an extraordinary...
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...
A breakthrough in biopsy efficiency The Brevera system streamlines the entire breast biopsy process from start to finish – with real-time imaging for instant verification and automated post-biopsy specimen handling. This has the potential to...
Expertly designed to optimize productivity ARIETTA 65 has been designed to perform quick and precise diagnosis in general imaging without compromising on productivity and workflow. This ultrasound platform combines productivity, enhanced tools...
BioZorb® 3D Bioabsorbable Marker The BioZorb® is a 3D implantable marker that consists of a spiral, bioabsorbable framework embedded with 6 permanent, titanium clips designed to precisely mark your surgical excision site. Designed to improve outcomes...